Joint Letter to CMS Advocates Against Adding Stelara to Self-Administered Drug List

The ACR, CSRO and Arthritis Foundation asked the Centers for Medicare & Medicaid Services to review the decision to add Stelara to the Self-Administered Drugs list, which would limit access for patients who can't self-administer.

Source: The Rheumatologist - July 6, 2020 Category: Rheumatology Authors: From the College Tags: Legislation & Advocacy COVID-19 Medicare Part B Medicare Part D self-administration Source Type: research